GLP‑1 medication for weight management: what you should know
Medication can be one part of weight management for some people. It is not suitable for everyone, and the decision to use it should follow an individual medical assessment. This guide explains what GLP‑1 medicines are, how they fit alongside lifestyle changes, and what to discuss with a healthcare professional.
Medication can be one part of weight management for some people. It is not suitable for everyone, and the decision to use it should follow an individual medical assessment. This guide explains what GLP‑1 medicines are, how they fit alongside lifestyle changes, and what to discuss with a healthcare professional.
GLP‑1 medicines act on pathways involved in appetite and blood sugar regulation. Some prescription medicines in this area are authorised for weight management in people who meet specific medical criteria. You may have encountered terms such as semaglutide, tirzepatide, Wegovy or Mounjaro. These names do not all mean the same thing: some are active substances, while others are brand names, and their approved uses can differ.
Who might be considered for treatment?
A clinician considers more than weight alone. Your medical history, body mass index, weight related health conditions, current medicines and previous efforts to manage weight all matter. Medication is generally considered alongside changes to nutrition, physical activity and other habits, rather than in isolation.
An online questionnaire cannot establish whether a particular medicine is appropriate for you. That requires an individual clinical decision.
What should you know about benefits and risks?
People respond differently to treatment. GLP‑1 related medicines can cause side effects, particularly digestive symptoms such as nausea, vomiting or diarrhoea. There may also be important precautions or reasons a medicine is unsuitable for an individual. A prescriber should explain the expected benefits, possible harms, monitoring and what to do if problems arise.
Treatment may need to continue for a substantial period, and weight regain after stopping is possible. It is sensible to discuss the longer term plan before starting.
What does medically supervised care involve?
Appropriate care starts with an assessment of your health and treatment goals. If medication is considered, a qualified prescriber decides whether to prescribe it and a pharmacist supplies it through the appropriate route. Follow-up matters: your care team should review your response, side effects and whether the treatment remains appropriate.
The Litevitae approach
Litevitae focuses on safe and sustainable weight management through medical assessment, personalised guidance and healthier habits. Where prescription treatment may be relevant, the choice is made through an individual clinical assessment. No particular medicine or result is guaranteed.
Our programme includes an at home blood collection kit and ISO certified laboratory diagnostic test of relevant blood biomarkers.
Considering support with your weight and metabolic health? Learn about the Litevitae programme and its assessment process.
